Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments. But the majority of healthcare practitioners still feel unprepared and insufficiently informed to make reasonable, evidence-based recommendations about medical cannabis.